306
Views
3
CrossRef citations to date
0
Altmetric
Review

Capsaicin 179-mg cutaneous patch in the treatment of post-surgical neuropathic pain: a scoping review of current evidence and place in therapy

Pages 1147-1158 | Received 01 Jul 2021, Accepted 27 Aug 2021, Published online: 11 Oct 2021

References

  • Maihofner C, Heskamp ML. Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study. Curr Med Res Opin. 2013;29:673–683.
  • Mankowski C, Cd P, Ernault E, et al. Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study. BMC Neurol. 2017;17(1): 80.
  • Fletcher D, Stamer UM, Pogatzki-Zahn E, et al. Chronic postsurgical pain in Europe: an observational study. Eur J Anaesthesiol. 2015;32(10):725–734.
  • Haroutiunian S, Nikolajsen L, Finnerup NB, et al. The neuropathic component in persistent postsurgical pain: a systematic literature review. Pain. 2013;154(1):95–102.
  • Prudhomme M, Legraas A, Delorme C, et al. Management of neuropathic pain induced by surgery: review of the literature by a group of experts specialized in pain management, anesthesia and surgery. J Visc Surg. 2020;157:43–52.
  • Kehlet H, Jensen TS, Woolf CJ, et al. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006;367(9522):1618–1625.
  • Dualé C, Ouchchane L, Schoeffler P, et al. Neuropathic aspects of persistent postsurgical pain: a French multicenter survey with a 6-month prospective follow-up. J Pain. 2014;15(1):24.e1–24.e20.
  • Hoper J, Helfert S, Heskamp ML, et al. High concentration capsaicin for treatment of peripheral neuropathic pain: effect on somatosensory symptoms and identification of treatment responders. Curr Med Res Opin. 2014;30:565–574.
  • Borsook D, Kussman BD, George E, et al. Surgically induced neuropathic pain: understanding the perioperative process. Ann Surg. 2013;257(3):403–412.
  • Shipton E. Post-surgical neuropathic pain. ANZ J Surg. 2008;78(7):548–555.
  • Peng Z, Li H, Zhang C, et al. A retrospective study of chronic post-surgical pain following thoracic surgery: prevalence, risk factors, incidence of neuropathic component, and impact on qualify of life. PLoS One. 2014;9(2):e90014.
  • Steyaert A, Lavand’homme P. Acute and chronic neuropathic pain after surgery: still a lot to learn. Eur J Anaesthesiol. 2017;34(10):650–651.
  • Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2): 162–173.
  • Sommer C, Cruccu G. Topical treatment of peripheral neuropathic pain: applying the evidence. J Pain Symptom Manage. 2017;53(3):614–629.
  • Palladini M, Boesl I, Koenig S, et al. Lidocaine medicated plaster, an additional potential treatment option for localized post-surgical neuropathic pain: efficacy and safety results of a randomized, placebo-controlled trial. Curr Med Res Opin. 2019;35(5):757–766.
  • Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17(9): 1113–e88.
  • Abdulahad AK, Snijder RJ, Panni MK, et al. A novel standard to evaluate the impact of therapeutic agents on patient safety - the BURDEN OF THERAPY((c) *). Contemp Clin Trials Commun. 2016;4:186–191.
  • Casale R, Symeonidou Z, Bartolo M, et al. Topical treatments for localized neuropathic pain. Curr Pain Headache Rep. 2017;21(3):15.
  • Humble SR, Dalton AJ, Li L, et al. A systematic review of therapeutic interventions to reduce acute and chronic post-surgical pain after amputation, thoracotomy or mastectomy. Eur J Pain. 2015;19(4):451–465.
  • Blair HA. Capsaicin 8% dermal patch: a review in peripheral neuropathic pain. Drugs. 2018;78(14):1489–1500.
  • Anand P, Dickenson A, Finco G, et al. Novel insights on the management of pain: highlights from the ‘Science of Relief’ meeting. Pain Manag. 2019;9:521–533.
  • Bonezzi C, Costantini A, Cruccu G, et al. Capsaicin 8% dermal patch in clinical practice: an expert opinion. Expert Opin Pharmacother. 2020;21(11):1377–1387.
  • Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMAScR): checklist and explanation. Ann Intern Med. 2018;169:467–473.
  • Mejdahl MK, Christoffersens KB, Andersen KG, et al. Development and validation of a screening tool for surgery-specific neuropathic pain: neuropathic pain scale for postsurgical patients. Pain Physician. 2019;22:E81–E90.
  • Glare P, Aubrey KR, Myles PS, et al. Transition from acute to chronic pain after surgery. Lancet. 2019;393(10180):1537–1546.
  • Correll D. Chronic postoperative pain: recent findings in understanding and management. F1000Res. 2017;6:1054.
  • Attal N, Bouhassira D, Baron R, et al. Diagnosis and assessment of neuropathic pain through questionnaires. Lancet Neurol. 2018;17(5):456–466.
  • Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70(18):1630–1635.
  • Cruccu G, Sommer C, Anand P, et al. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol. 2010;17(8): 1010–1018.
  • Feller L, Khammissa RAG, Bouckaert M, et al. Pain: persistent postsurgery and bone cancer-related pain. J Int Med Res. 2019;47:528–543.
  • Chapman CR, Vierck CJ. The transition of acute postoperative pain to chronic pain: an integrative overview of research on mechanisms. J Pain. 2017;18(4):359 e1–359.e38.
  • Fregoso G, Wang A, Tseng K, et al. Transition from acute to chronic pain: evaluating risk for chronic postsurgical pain. Pain Physician. 2019;22:479–488.
  • Richebe P, Capdevila X, Rivat C, et al. Persistent postsurgical pain: pathophysiology and preventative pharmacologic considerations. Anesthesiology. 2018;129(3):590–607.
  • Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10(9):895–926.
  • Schug SA, Lavandʼhomme P, Barke A, et al. The IASP classification of chronic pain for ICD-11: chronic postsurgical or posttraumatic pain. Pain. 2019;160:45–52.
  • Lange JFM, Kaufmann R, Wijsmuller AR, et al. An international consensus algorithm for management of chronic postoperative inguinal pain. Hernia. 2015;19(1):33–43.
  • Ji RR, Chamessian A, Zhang YQ, et al. Pain regulation by non-neuronal cells and inflammation. Science. 2016;354(6312):572–577.
  • Gracely RH, Lynch SA, Bennett GJ, et al. Painful neuropathy: altered central processing maintained dynamically by peripheral input. Pain. 1992;51(2):175–194.
  • Dickenson AH, Patel R. Sense and sensibility-logical approaches to profiling in animal models. Pain. 2018;159(7):1426–1428.
  • Vay L, Gu C, McNaughton PA, et al. The thermo-TRP ion channel family: properties and therapeutic implications. Br J Pharmacol. 2012;165(4):787–801.
  • Kremeyer B, Lopera F, Cox JJ, et al. A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome. Neuron. 2010;66(5):671–680.
  • Anand P, Bley K. Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch. Br J Anaesth. 2011;107(4):490–502.
  • Nolano M, Simone DA, Wendelschafer-Crabb G, et al. Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation. Pain. 1999;81(1):135–145.
  • Haanpaa M, Cruccu G, Nurmikko TJ, et al. Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain. Eur J Pain. 2016;20(2):316–328.
  • Baron R, Allegri M, Correa-Illanes G, et al. The 5% lidocaine-medicated plaster: its inclusion in international treatment guidelines for treating localized neuropathic pain, and clinical evidence supporting its use. Pain Ther. 2016;5(2):149–169.
  • O’Neill J, Brock C, Olesen AE, et al. Unravelling the mystery of capsaicin: a tool to understand and treat pain. Pharmacol Rev. 2012;64(4):939–971.
  • Chanda S, Erexson G, Riach C, et al. Genotoxicity studies with pure trans-capsaicin. Mutat Res. 2004;557(1):85–97.
  • McCormack PL. Capsaicin dermal patch: in non-diabetic peripheral neuropathic pain. Drugs. 2010;70(14):1831–1842.
  • Cruccu G, Nurmikko TJ, Ernault E, et al. Superiority of capsaicin 8% patch versus oral pregabalin on dynamic mechanical allodynia in patients with peripheral neuropathic pain. Eur J Pain. 2018;22(4):700–706.
  • Bischoff JM, Ringsted TK, Petersen M, et al. A capsaicin (8%) patch in the treatment of severe persistent inguinal postherniorrhaphy pain: a randomized, double-blind, placebo-controlled trial. PLoS One. 2014;9(10):e109144.
  • Galvez R, Navez ML, Moyle G, et al. Capsaicin 8% patch repeat treatment in nondiabetic peripheral neuropathic pain: a 52-week, open-label, single-arm, safety study. Clin J Pain. 2017;33:921–931.
  • Tamburini N, Bollini G, Volta CA, et al. Capsaicin patch for persistent postoperative pain after thoracoscopic surgery, report of two cases. J Vis Surg. 2018;4:51.
  • Hansson P, Jensen TS, Kvarstein G, et al. Pain-relieving effectiveness, quality of life and tolerability of repeated capsaicin 8% patch treatment of peripheral neuropathic pain in Scandinavian clinical practice. Eur J Pain. 2018;22(5):941–950.
  • Zis P, Apsokardos A, Isaia C, et al. Posttraumatic and postsurgical neuropathic pain responsive to treatment with capsaicin 8% topical patch. Pain Physician. 2014;17:E213–8.
  • Dworkin RH, Turk DC, Peirce-Sandner S, et al. Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations. Pain. 2012;153(6):1148–1158.
  • Roberts C, Morgan L, Hall K, et al. A case study in the use of capsaicin in the treatment of neuropathic chest wall pain and post-thoracotomy intercostal neuralgia. Open J Anesthesiol. 2012;2(04):99–101.
  • Werner MU, Kongsgaard EU. Defining persistent post-surgical pain: is an update required?. Br J Anaesth. 2014;113(1):1–4.
  • Chou R, Gordon DB, de Leon-Casasola OA, et al. Management of postoperative pain: a clinical practice guideline from the American pain society, the American society of regional anesthesia and pain medicine, and the American society of anesthesiologists’ committee on regional anesthesia, executive committee, and administrative council. J Pain. 2016;17:131–157.
  • Beloeil H, Sion B, Rousseau C, et al. Early postoperative neuropathic pain assessed by the DN4 score predicts an increased risk of persistent postsurgical neuropathic pain. Eur J Anaesthesiol. 2017;34(10):652–657.
  • Torebjork HE, Lundberg LE, LaMotte RH, et al. Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J Physiol. 1992;448:765–780.
  • Jancso N, Jancso-Gabor A, Szolcsanyi J, et al. The role of sensory nerve endings in neurogenic inflammation induced in human skin and in the eye and paw of the rat. Br J Pharmacol Chemother. 1968;33:32–41.
  • Wagner T, Roth-Daniek A, Sell A, et al. Capsaicin 8% patch for peripheral neuropathic pain: review of treatment best practice from ‘real-world’ clinical experience. Pain Manag. 2012;2:239–250.
  • Vinik AI, Perrot S, Vinik EJ, et al. Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study. BMC Neurol. 2016;16(1): 251.
  • Casale R, Di Matteo M, Minella CE, et al. Reduction of painful area as new possible therapeutic target in post-herpetic neuropathic pain treated with 5% lidocaine medicated plaster: a case series. J Pain Res. 2014;7:353–357.
  • Costigan M, Scholz J, Woolf CJ, et al. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci. 2009;32(1):1–32.
  • Kudel I, Hopps M, Cappelleri JC, et al. Characteristics of patients with neuropathic pain syndromes screened by the painDETECT questionnaire and diagnosed by physician exam. J Pain Res. 2019;12:255–268.
  • Reimer M, Helfert SM, Baron R, et al. Phenotyping neuropathic pain patients: implications for individual therapy and clinical trials. Curr Opin Support Palliat Care. 2014;8(2):124–129.
  • Baron R, Hans G, Dickenson AH, et al. Peripheral input and its importance for central sensitization. Ann Neurol. 2013;74(5):630–636.
  • Jensen TS, Finnerup NB. Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms. Lancet Neurol. 2014;13(9):924–935.
  • Campbell CM, Kipnes MS, Stouch BC, et al. Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy. Pain. 2012;153(9):1815–1823.
  • Derry S, Rice AS, Cole P, et al. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Systematic Rev. 2017;1(1):CD007393.
  • van Hecke O, Austin SK, Khan RA, et al. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain. 2014;155(4):654–662.
  • Simanski CJ, Althaus A, Hoederath S, et al. Incidence of chronic postsurgical pain (CPSP) after general surgery. Pain Med. 2014;15:1222–1229.
  • Johansen A, Schirmer H, Stubhaug A, et al. Persistent post-surgical pain and experimental pain sensitivity in the Tromso study: comorbid pain matters. Pain. 2014;155:341–348.
  • Guimaraes-Pereira L, Reis P, Abelha F, et al. Castro-Lopes JM. Persistent postoperative pain after cardiac surgery: a systematic review with meta-analysis regarding incidence and pain intensity. Pain. 2017;158(10):1869–1885.
  • Phillips JR, Hopwood B, Arthur C, et al. The natural history of pain and neuropathic pain after knee replacement: a prospective cohort study of the point prevalence of pain and neuropathic pain to a minimum three-year follow-up. Bone Joint J. 2014;96-B(9):1227–1233.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.